A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This study presents the two-dimensional (2D) scratch wound migration assay and the three-dimensional (3D) spheroid sprouting assay, along with their respective downstream analysis methods, including RNA extraction and immunocytochemistry, as suitable assays to study angiogenesis in vitro.
Angiogenesis plays a crucial role in both physiological and pathological processes within the body including tumor growth or neovascular eye disease. A detailed understanding of the underlying molecular mechanisms and reliable screening models are essential for targeting diseases effectively and developing new therapeutic options. Several in vitro assays have been developed to model angiogenesis, capitalizing on the opportunities a controlled environment provides to elucidate angiogenic drivers at a molecular level and screen for therapeutic targets.
This study presents workflows for investigating angiogenesis in vitro using human umbilical vein endothelial cells (HUVECs). We detail a scratch wound migration assay utilizing a live cell imaging system measuring endothelial cell migration in a 2D setting and the spheroid sprouting assay assessing endothelial cell sprouting in a 3D setting provided by a collagen matrix. Additionally, we outline strategies for sample preparation to enable further molecular analyses such as transcriptomics, particularly in the 3D setting, including RNA extraction as well as immunocytochemistry. Altogether, this framework offers scientists a reliable and versatile toolset to pursue their scientific inquiries in in vitro angiogenesis assays.
Angiogenesis, which refers to the formation of new blood vessels from pre-existing ones1, is a crucial process during physiological development and pathologic conditions. It is indispensable for providing energy to highly metabolically active tissues such as the retina2 or the developing central nervous system3 and during the healing of damaged tissue4. Abnormal angiogenesis, on the other hand, is the basis for numerous diseases. Solid tumors, such as colorectal cancer or non-small cell lung cancer, facilitate their growth and the necessary energy supply by promoting angiog....
1. HUVEC cell culture
NOTE: Perform all following steps under sterile working conditions (sterile working bench).
For the migration assay, it is crucial to thoroughly examine the images captured at the t = 0 h time point to ensure the presence of a fully formed cell monolayer is accurately detected by the system (Figure 1B). Additionally, the clarity and straightness of the scratch border should be confirmed (Figure 1B). The cell-free area ought to be largely free of debris. At the end of the assay, a group stimulated with, for example, 25 ng/mL VEGF as a positive control s.......
In this report, we presented a spectrum of techniques with functional and molecular readouts to study angiogenesis in vitro.
The migration assay represents a well-established technique used across all fields of wet laboratory work. We chose the commercially available live-cell imaging approach to take advantage of the 96-well format suitable for screening and dose-response experiments, the standardized and reproducible wound size created by the WoundMaker tool, the opportunity to ob.......
The authors thank Sophie Krüger and Gabriele Prinz for their excellent technical support. We thank Sebastian Maier for developing the ImageJ plugin to quantify spheroid sprouts and the Lighthouse Core Facility, Zentrum für Translationale Zellforschung (ZTZ), Department of Medicine I, University Hospital Freiburg for the use of the IncuCyte system. The graphics were created with biorender.com. This work was supported by the Deutsche Forschungsgemeinschaft [Bu3135/3-1 + Bu3135/3-2 to F.B], the Medizinische Fakultät der Albert-Ludwigs- Universität Freiburg [Berta-Ottenstein-Program for Clinician Scientists and Advanced Clinician Scientists to F.B.], t....
Name | Company | Catalog Number | Comments |
10x Medium 199 | Sigma-Aldrich | M0650 | |
2-(4-(2-Hydroxyethyl)1-piperazinyl)-ethan-sulfonsäure | PAN-Biotec | P05-01100 | HEPES |
Alexa Fluor 647-conjugated AffiniPure F(ab)‘2-Fragment | Jackson IR | 115-606-072 | |
Axio Vert. A1 | Zeiss | ||
CapturePro 2.10.0.1 | JENOTIK Optical Systems | ||
Collagen Type 1 rat tail | Corning | 354236 | |
Collagenase D | Roche | 11088858001 | |
Endothelial Cell Basal Medium | Lonza | CC-3156 | EBM |
Endothelial Cell Growth Medium | Lonza | CC-3162 | EGM |
Ethylenediaminetetraacetic acid | Serva | 11290.02 | EDTA |
Fetal bovine serum | Bio&SELL | S 0615 | FBS |
Human Umbilical Vein Endothelial Cells, pooled | Lonza | C2519A | HUVEC |
IncuCyte ImageLock 96-well plates | Sartorius | 4379 | |
Incucyte S3 Live-Cell Analysis System | Sartorius | ||
Methocel | Sigma | m-0512 | |
Microvascular Endothelial Cell Medium with 10% FBS | PB-MH-100-4090-GFP | PELOBiotech | |
NaOH | Carl Roth | P031.2 | |
Phalloidin-Fluorescein Isothiocyanate Labeled (0.5 mg/mL Methanol) | Sigma-Aldrich | P5282-.1MG | Phalloidin-FITC |
Phosphate-buffered saline | Thermo Fisher Scientfic | 14190-094 | PBS |
Primary Human Retinal Microvascular Endothelial Cells | Cell Systems | ACBRI 181 | |
ProLong Glass Antifade Mountant with NucBlue | Invitrogen by ThermoFisher Scientific | 2260939 | |
QIAzol Lysis Reagent | QIAGEN | 79306 | |
recombinant human Vascular Endothelial Growth Factor | PeproTech | 100-20 | VEGF |
Squared petri dish | Greiner | 688102 | |
Trizol | Qiagen | 79306 | |
Trypsin | PAN-Biotec | P10-024100 | |
VEGF-R2 (monoclonal) | ThermoFisher Scientific Inc. | B.309.4 | |
WoundMaker | Sartorius | 4493 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved